Dr Peter Lanyon is a Consultant Rheumatologist at Nottingham University Hospitals NHS Trust and a Past President of the British Society for Rheumatology.

He is the Rare Diseases Clinical Lead, in the National Disease Registration Service (NDRS), NHS England. NDRS is an international leader in population-based disease registration services, real-world clinical data, quality assurance, surveillance, analysis and monitoring.

As Joint National Clinical Lead for the Getting It Right First Time (GIRFT) rheumatology workstream, he uses national NHS datasets to identify, clinically interpret, and address variation in NHS care. GIRFT is part of an aligned set of programmes within NHS England, designed to improve the treatment and care of patients through in-depth clinically led review of services, benchmarking, and presenting a data-driven evidence base to support change.

He is Co-Chair of the Rare Autoimmune Rheumatic Disease Alliance (RAIRDA), which brings together patient organisations to campaign for improved care for people living with rare autoimmune rheumatic diseases in the UK.

Peter previously chaired the NHS England Clinical Reference Group for Specialised Rheumatology, and led work that designed, prioritised and implemented Commissioning Policies enabling access to high-cost treatments for rare autoimmune diseases.